What Researchers Did
Researchers investigated the safety of hyperbaric oxygen therapy (HBOT) and its effect on central airway stenosis (CAS) in lung transplant patients with extensive necrotic airway plaques.
What They Found
Hyperbaric oxygen therapy (HBOT) was well tolerated by ten lung transplant patients. While the incidence of central airway stenosis was similar between HBOT-treated and reference patients (70% vs 87%, P=.34), significantly fewer HBOT patients required airway stents (10% vs 56%, P=.03).
What This Means for Canadian Patients
Canadian lung transplant patients experiencing necrotic airway plaques may benefit from hyperbaric oxygen therapy as a safe treatment option. This therapy could potentially reduce the need for invasive airway stent placements, improving post-transplant quality of life.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
This was a pilot study with a small sample size, limiting the generalizability of the findings.